ENTA

Enanta Pharmaceuticals, Inc. News Headlines

$37.57
*  
0.61
 negative 
1.65%
Get ENTA Alerts
*Delayed - data as of Apr. 24, 2014 12:57 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENTA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dr. Reddy's Launches Generic Antara - Analyst Blog
4/23/2014 7:00:01 PM - Zacks.com

AbbVie Files for HCV Combination Therapy in U.S. - Analyst Blog
4/23/2014 5:21:01 PM - Zacks.com

QRxPharma Snubbed Again, Illumina Shines, ENTA Gets Rich, LLY Opens Wallet
4/23/2014 2:59:00 AM - RTT News

Karyopharm Starts Phase I Study - Analyst Blog
4/22/2014 5:10:01 PM - Zacks.com

Enanta Pharma Announces NDA Submission To FDA For Hepatitis C Treatment
4/22/2014 12:35:00 PM - RTT News

Galectin Therapeutics Rises on GR-MD-02 Update - Analyst Blog
4/21/2014 4:45:01 PM - Zacks.com

Has A Streamlined FDA Raised The Value Of Drug Stocks?
4/17/2014 5:33:00 PM - Investor's Business Daily

Dr. Reddy's Launches Generic Lunesta - Analyst Blog
4/17/2014 12:44:01 PM - Zacks.com

Legal Settlement for Astellas Pharma - Analyst Blog
4/17/2014 12:41:01 PM - Zacks.com

Actelion Beats on Q1 Earnings and Sales - Analyst Blog
4/17/2014 11:00:01 AM - Zacks.com

Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the Tape
4/17/2014 9:04:01 AM - Zacks.com

Positive Data on AbbVie's HCV Program - Analyst Blog
4/14/2014 4:50:01 PM - Zacks.com

AbbVie To Present TURQUOISE-II Study Results At ILC
4/12/2014 1:42:00 AM - RTT News

Commit To Purchase Enanta Pharmaceuticals At $35, Earn 20.7% Annualized Using Options
3/10/2014 11:43:37 AM - BNK Invest

AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog
3/4/2014 6:10:01 PM - Zacks.com

A Picture Is Worth A Thousand Words: Implications From Sovaldi Treatment Trends
2/24/2014 3:24:00 PM - Seeking Alpha

Sector Update: Healthcare
2/13/2014 9:53:27 AM - MT Newswires

Sector Update: Healthcare Shares Fairly Flat; Acorda Q4 Earnings Top Street View
2/13/2014 9:52:59 AM - MT Newswires

Enanta (ENTA) Worth Watching: Stock Rises 13.4% - Tale of the Tape
2/3/2014 10:46:01 AM - Zacks.com

Enanta Announces Results From Four All-Oral, Interferon-Free, Phase 3 Studies
1/31/2014 8:23:00 AM - RTT News

A Glance At Our Winners And Losers In 2013
12/31/2013 5:22:00 PM - Seeking Alpha

Update on Amarin's Vascepa - Analyst Blog
12/27/2013 12:02:02 PM - Zacks.com

Sucampo Reports Data - Analyst Blog
12/26/2013 6:00:01 PM - Zacks.com

Update on NVO's Victoza - Analyst Blog
12/26/2013 1:10:01 PM - Zacks.com

EU Approves Actelion's Opsumit - Analyst Blog
12/24/2013 12:45:01 PM - Zacks.com